Showing results (181-190 of 219) with videos related to

Sort By:
Pageof 22
The Journal of Infectious Diseases|December 23, 2017
Evidence for Congenital Zika Virus Infection From Neutralizing Antibody Titers in Maternal Sera, Northeastern BrazilAndres Moreira-Soto, Manoel Sarno, Celia Pedroso, et al.
Journal of the International AIDS Society|January 31, 2019
Trends and predictors of non-communicable disease multimorbidity among adults living with HIV and receiving antiretroviral therapy in BrazilJessica L Castilho, Maria M Escuder, Valdiléa Veloso, et al.
Frontiers in Public Health|March 18, 2025
Multicenter cross-sectional study of HTLV-1 prevalence and associated risk factors in epidemiologically relevant groups across BrazilCarlos Brites, Prince Baffour Tonto, Antonio C Vallinoto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2025
Efficacy and Safety of Dual Therapy With Dolutegravir/Lamivudine in Treatment-naive Persons With CD4 Counts <200/mm3: 48-Week Results of the DOLCE StudyMaria Ines Figueroa, Carlos Brites, Diego Cecchini, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|February 22, 2015
High degree of concordance between flow cytometry and geno2pheno methods for HIV-1 tropism determination in proviral DNAAlex José Leite Torres, Luis Fernando de Macedo Brígido, Marcos Herculano Nunes Abrahão, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 2, 2022
Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase 3, Noninferiority SALSA Randomized TrialJosep M Llibre, Carlos Brites, Chien-Yu Cheng, et al.
The Journal of General Virology|February 5, 2010
Genomic features and evolutionary constraints in Saffold-like cardiovirusesJan Felix Drexler, Sigrid Baumgarte, Luciano Kleber de Souza Luna, et al.
The Lancet. Infectious Diseases|February 9, 2019
Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trialMichael Aboud, Richard Kaplan, Johannes Lombaard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological TestsWen-Yang Tsai, Han Ha Youn, Carlos Brites, et al.
AIDS and Behavior|September 3, 2024
Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine: 48-Week Results from the SALSA StudyPrincy Kumar, Amanda E Clarke, Celia Jonsson-Oldenbüttel, et al.
Pageof 22